| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cadherin binding | RSL1D1 ARHGEF16 BSG DHX29 DOCK9 KTN1 LARP1 SHTN1 PDLIM5 TLN1 MACF1 MARK2 SEPTIN7 | 3.05e-05 | 339 | 195 | 13 | GO:0045296 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 9.49e-05 | 2 | 195 | 2 | GO:0016639 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase [NAD(P)+] activity | 9.49e-05 | 2 | 195 | 2 | GO:0004353 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NAD+) activity | 9.49e-05 | 2 | 195 | 2 | GO:0004352 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NADP+) activity | 9.49e-05 | 2 | 195 | 2 | GO:0004354 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | CDK8 DCAF1 CDK14 AURKA MAPKAPK3 MAP3K19 CAMK2D CAMK2G SIK3 CSNK1G2 MARK4 MARK2 | 2.48e-04 | 363 | 195 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | muscle alpha-actinin binding | 3.83e-04 | 15 | 195 | 3 | GO:0051371 | |
| GeneOntologyCellularComponent | asymmetric synapse | MAP2 AURKA PRR12 GPR158 LRFN5 PLEKHA5 DRP2 ABI3BP GIT1 CAMK2G PPP1R9A ARFGEF2 DGKZ DICER1 PDLIM5 MACF1 INSYN2B | 2.99e-06 | 477 | 197 | 17 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic density | MAP2 AURKA PRR12 GPR158 LRFN5 PLEKHA5 DRP2 ABI3BP GIT1 CAMK2G PPP1R9A DGKZ DICER1 PDLIM5 MACF1 INSYN2B | 6.26e-06 | 451 | 197 | 16 | GO:0014069 |
| GeneOntologyCellularComponent | neuron to neuron synapse | MAP2 AURKA PRR12 GPR158 LRFN5 PLEKHA5 DRP2 ABI3BP GIT1 CAMK2G PPP1R9A ARFGEF2 DGKZ DICER1 PDLIM5 MACF1 INSYN2B | 1.01e-05 | 523 | 197 | 17 | GO:0098984 |
| GeneOntologyCellularComponent | postsynapse | MAP2 KCTD8 ZZEF1 AURKA PRR12 GPR158 SLC24A2 LRFN5 PLEKHA5 AP3D1 CAP1 DRP2 ABI3BP GIT1 CAMK2D CAMK2G PPP1R9A ARFGEF2 DGKZ DICER1 PDLIM5 MACF1 INSYN2B MARK2 SEPTIN7 | 1.15e-05 | 1018 | 197 | 25 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic specialization | MAP2 AURKA PRR12 GPR158 LRFN5 PLEKHA5 DRP2 ABI3BP GIT1 CAMK2G PPP1R9A DGKZ DICER1 PDLIM5 MACF1 INSYN2B | 2.41e-05 | 503 | 197 | 16 | GO:0099572 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CDK8 DCAF1 NCOA6 ERCC4 INO80C BCOR COPS7A SALL1 NFIL3 BOD1L1 ZNF541 TCF7 INTS12 NUP98 NSD1 SAE1 MED13L HDAC7 SYNE4 PCF11 POLR1D KANSL1 CEBPZ ASXL3 ARID2 SMARCA4 SRRM2 ELL | 9.84e-05 | 1377 | 197 | 28 | GO:0140513 |
| GeneOntologyCellularComponent | filamentous actin | 4.39e-04 | 38 | 197 | 4 | GO:0031941 | |
| GeneOntologyCellularComponent | mitotic spindle pole | 7.08e-04 | 43 | 197 | 4 | GO:0097431 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 7.15e-04 | 75 | 197 | 5 | GO:0035097 | |
| GeneOntologyCellularComponent | cell cortex | PDLIM2 CAP1 PPP1R9A PARD3B CLIP4 CSNK1G2 MACF1 ERC2 MARK2 SEPTIN7 GAB1 | 8.23e-04 | 371 | 197 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 8.67e-04 | 5 | 197 | 2 | GO:0005954 | |
| GeneOntologyCellularComponent | anchoring junction | PDLIM7 CYTH1 GIT2 BSG PDLIM2 CAP1 USP53 GIT1 CAMK2D LAMA3 MAGI3 PARD3B LCP2 ARPC5 PDLIM5 TLN1 PATJ FYB1 GAB1 PDZD2 | 9.42e-04 | 976 | 197 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | actin cytoskeleton | MAP2 PDLIM7 PDLIM2 CAP1 PPP1R9A SPECC1 ARPC5 PDLIM5 MSRA ACTR1B MACF1 MARK2 SEPTIN7 FYB1 | 1.17e-03 | 576 | 197 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | cell-cell junction | PDLIM7 CYTH1 PDLIM2 USP53 CAMK2D LAMA3 MAGI3 PARD3B LCP2 PDLIM5 TLN1 PATJ GAB1 PDZD2 | 1.49e-03 | 591 | 197 | 14 | GO:0005911 |
| Domain | COE | 4.59e-06 | 4 | 197 | 3 | PS01345 | |
| Domain | Transcription_factor_COE | 4.59e-06 | 4 | 197 | 3 | IPR003523 | |
| Domain | COE_HLH | 4.59e-06 | 4 | 197 | 3 | IPR032201 | |
| Domain | COE_DBD | 4.59e-06 | 4 | 197 | 3 | IPR032200 | |
| Domain | Transcription_factor_COE_CS | 4.59e-06 | 4 | 197 | 3 | IPR018350 | |
| Domain | COE1_HLH | 4.59e-06 | 4 | 197 | 3 | PF16423 | |
| Domain | COE1_DBD | 4.59e-06 | 4 | 197 | 3 | PF16422 | |
| Domain | PDZ | 2.79e-05 | 148 | 197 | 9 | SM00228 | |
| Domain | - | 3.10e-05 | 150 | 197 | 9 | 2.30.42.10 | |
| Domain | PDZ | 3.27e-05 | 151 | 197 | 9 | PS50106 | |
| Domain | PDZ | 3.45e-05 | 152 | 197 | 9 | IPR001478 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 8.81e-05 | 69 | 197 | 6 | IPR020636 | |
| Domain | ELFV_dehydrog_N | 1.11e-04 | 2 | 197 | 2 | PF02812 | |
| Domain | GIT | 1.11e-04 | 2 | 197 | 2 | SM00555 | |
| Domain | Glu/Leu/Phe/Val_DH_C | 1.11e-04 | 2 | 197 | 2 | IPR006096 | |
| Domain | Glu/Leu/Phe/Val_DH_dimer_dom | 1.11e-04 | 2 | 197 | 2 | IPR006097 | |
| Domain | Glu/Leu/Phe/Val_DH | 1.11e-04 | 2 | 197 | 2 | IPR006095 | |
| Domain | GIT1_C | 1.11e-04 | 2 | 197 | 2 | PF12205 | |
| Domain | GIT1/2_CC | 1.11e-04 | 2 | 197 | 2 | IPR032352 | |
| Domain | ELFV_dehydrog | 1.11e-04 | 2 | 197 | 2 | PF00208 | |
| Domain | NAD_bind_Glu_DH | 1.11e-04 | 2 | 197 | 2 | IPR033922 | |
| Domain | GIT_SHD | 1.11e-04 | 2 | 197 | 2 | PF08518 | |
| Domain | GLFV_DEHYDROGENASE | 1.11e-04 | 2 | 197 | 2 | PS00074 | |
| Domain | GIT_CC | 1.11e-04 | 2 | 197 | 2 | PF16559 | |
| Domain | GIT1_C | 1.11e-04 | 2 | 197 | 2 | IPR022018 | |
| Domain | GIT_SHD | 1.11e-04 | 2 | 197 | 2 | IPR013724 | |
| Domain | ELFV_dehydrog | 1.11e-04 | 2 | 197 | 2 | SM00839 | |
| Domain | Glu/Leu/Phe/Val_DH_AS | 1.11e-04 | 2 | 197 | 2 | IPR033524 | |
| Domain | PDZ | 1.27e-04 | 141 | 197 | 8 | PF00595 | |
| Domain | IPT | 1.74e-04 | 27 | 197 | 4 | SM00429 | |
| Domain | TIG | 3.02e-04 | 31 | 197 | 4 | PF01833 | |
| Domain | Fox-1_C | 3.30e-04 | 3 | 197 | 2 | PF12414 | |
| Domain | Fox-1_C_dom | 3.30e-04 | 3 | 197 | 2 | IPR025670 | |
| Domain | UPF0560 | 3.30e-04 | 3 | 197 | 2 | PF10577 | |
| Domain | RNA-bd_Fox-1 | 3.30e-04 | 3 | 197 | 2 | IPR017325 | |
| Domain | Uncharacterised_FAM171 | 3.30e-04 | 3 | 197 | 2 | IPR018890 | |
| Domain | IPT | 3.43e-04 | 32 | 197 | 4 | IPR002909 | |
| Domain | CaMKII_AD | 6.55e-04 | 4 | 197 | 2 | PF08332 | |
| Domain | MARK/par1 | 6.55e-04 | 4 | 197 | 2 | IPR033624 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 6.55e-04 | 4 | 197 | 2 | IPR013543 | |
| Domain | Protein_kinase_ATP_BS | CDK8 CDK14 AURKA BMX MAPKAPK3 MAP3K19 CAMK2D CAMK2G SIK3 CSNK1G2 MARK4 MARK2 | 7.20e-04 | 379 | 197 | 12 | IPR017441 |
| Domain | PH | 7.48e-04 | 229 | 197 | 9 | PF00169 | |
| Domain | ARM-type_fold | DCAF1 LYST URB1 ASPM HEATR5B AP3D1 GPRASP2 DOCK9 ARFGEF2 CEBPZ ARID2 | 9.79e-04 | 339 | 197 | 11 | IPR016024 |
| Domain | KA1 | 1.08e-03 | 5 | 197 | 2 | PF02149 | |
| Domain | KA1_dom | 1.08e-03 | 5 | 197 | 2 | IPR001772 | |
| Domain | KA1 | 1.08e-03 | 5 | 197 | 2 | PS50032 | |
| Domain | - | 1.08e-03 | 5 | 197 | 2 | 3.30.310.80 | |
| Domain | UBA | 1.17e-03 | 44 | 197 | 4 | IPR015940 | |
| Domain | Ser/Thr_kinase_AS | CDK8 CDK14 AURKA MAPKAPK3 MAP3K19 CAMK2D CAMK2G SIK3 CSNK1G2 MARK4 MARK2 | 1.48e-03 | 357 | 197 | 11 | IPR008271 |
| Domain | WW | 1.50e-03 | 47 | 197 | 4 | PF00397 | |
| Domain | UBA | 1.50e-03 | 47 | 197 | 4 | PS50030 | |
| Domain | S_TKc | CDK8 CDK14 AURKA MAPKAPK3 MAP3K19 CAMK2D CAMK2G SIK3 CSNK1G2 MARK4 MARK2 | 1.55e-03 | 359 | 197 | 11 | SM00220 |
| Domain | DUF4749 | 1.61e-03 | 6 | 197 | 2 | PF15936 | |
| Domain | DUF4749 | 1.61e-03 | 6 | 197 | 2 | IPR031847 | |
| Domain | WW | 1.63e-03 | 48 | 197 | 4 | SM00456 | |
| Domain | PROTEIN_KINASE_ST | CDK8 CDK14 AURKA MAPKAPK3 MAP3K19 CAMK2D CAMK2G SIK3 CSNK1G2 MARK4 MARK2 | 1.65e-03 | 362 | 197 | 11 | PS00108 |
| Domain | PH_dom-like | CYTH1 TBC1D2B ARHGEF16 LYST RTKN2 BMX PLEKHA5 PREX1 DOCK9 ARHGEF10L TLN1 GAB1 | 1.95e-03 | 426 | 197 | 12 | IPR011993 |
| Domain | WW_DOMAIN_1 | 2.04e-03 | 51 | 197 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 2.04e-03 | 51 | 197 | 4 | PS50020 | |
| Domain | WW_dom | 2.19e-03 | 52 | 197 | 4 | IPR001202 | |
| Domain | CAMSAP_CH | 2.24e-03 | 7 | 197 | 2 | PF11971 | |
| Domain | TFS2M | 2.24e-03 | 7 | 197 | 2 | SM00510 | |
| Domain | KA1/Ssp2_C | 2.24e-03 | 7 | 197 | 2 | IPR028375 | |
| Domain | CAMSAP_CH | 2.24e-03 | 7 | 197 | 2 | IPR022613 | |
| Domain | TFIIS_M | 2.24e-03 | 7 | 197 | 2 | PF07500 | |
| Domain | Pkinase | CDK8 CDK14 AURKA MAPKAPK3 MAP3K19 CAMK2D CAMK2G SIK3 CSNK1G2 MARK4 MARK2 | 2.46e-03 | 381 | 197 | 11 | PF00069 |
| Domain | AT_hook | 2.81e-03 | 27 | 197 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 2.81e-03 | 27 | 197 | 3 | IPR017956 | |
| Domain | PH | 2.84e-03 | 278 | 197 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 2.91e-03 | 279 | 197 | 9 | PS50003 | |
| Domain | TFIIS_cen_dom | 2.97e-03 | 8 | 197 | 2 | IPR003618 | |
| Domain | - | 2.97e-03 | 8 | 197 | 2 | 1.10.472.30 | |
| Domain | TFIIS_CENTRAL | 2.97e-03 | 8 | 197 | 2 | PS51321 | |
| Domain | PH_domain | 2.98e-03 | 280 | 197 | 9 | IPR001849 | |
| Domain | - | CYTH1 TBC1D2B ARHGEF16 RTKN2 BMX PLEKHA5 PREX1 DOCK9 ARHGEF10L TLN1 GAB1 | 3.00e-03 | 391 | 197 | 11 | 2.30.29.30 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 NCOA6 MAP2 EXPH5 KCTD8 CDK14 ARHGEF16 LYST BMX PLEKHA5 BOD1L1 CAMSAP1 USP53 INTS12 SASH1 TTC28 GIT1 CAMK2D WWP2 LARP1 MAGI3 PARD3B SIK3 SHTN1 SPECC1 HDAC7 PPM1A VPS13D FAM171A2 CEP89 MARK4 ANKRD17 MACF1 MARK2 PATJ SRRM2 GAB1 | 1.30e-21 | 861 | 201 | 37 | 36931259 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | RSL1D1 PDLIM7 ARHGEF16 BSG PLEKHA5 DHX29 EPN3 DOCK9 KTN1 LARP1 MAGI3 FAM171B SHTN1 SPECC1 PDLIM5 TLN1 MACF1 MARK2 SEPTIN7 PATJ GAB1 | 1.89e-11 | 565 | 201 | 21 | 25468996 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | EXPH5 CDK14 ARHGEF16 GPR158 BSG PLEKHA5 CAMSAP1 EPN3 USP53 DOCK9 PPP1R9A ARFGEF2 ATAD2 SPECC1 FAM171A2 CSNK1G2 MARK2 PATJ FYB1 TXLNG GAB1 | 2.16e-11 | 569 | 201 | 21 | 30639242 |
| Pubmed | TET2 NCOA6 TBC1D2B BCOR CDK14 ZZEF1 PLEKHA5 USP53 NYAP2 SASH1 LARP1 DIDO1 SIK3 DICER1 ARHGEF10L ZNF532 TTLL4 ANKRD17 UNK KDM4A | 4.34e-11 | 529 | 201 | 20 | 14621295 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RSL1D1 PDLIM7 GIT2 URB1 CAMSAP1 DHX29 GIT1 EML4 CAMK2D CAMK2G KTN1 LARP1 C16orf96 DICER1 PDLIM5 POLR1D MBNL2 CEBPZ TLN1 ANKRD17 UNK MACF1 TXLNG | 4.56e-11 | 724 | 201 | 23 | 36232890 |
| Pubmed | NCOA6 GIT2 URB1 GPR158 PLEKHA5 PREX1 TTC28 DOCK9 SIK3 MED13L DICER1 TLN1 MACF1 ERC2 | 6.54e-11 | 225 | 201 | 14 | 12168954 | |
| Pubmed | CYTH1 GIT2 BCOR GPR158 PLEKHA5 CAMSAP1 NYAP2 GIT1 EBF3 CAMK2D CAMK2G KTN1 PPP1R9A NSD1 DIDO1 DGKZ SIK3 SHTN1 FAM171A2 ATF7IP SMARCA4 ANKRD17 MACF1 ERC2 SEPTIN7 | 4.28e-10 | 963 | 201 | 25 | 28671696 | |
| Pubmed | EXPH5 RTKN2 PLEKHA5 CPLANE1 USP53 ABI3BP KTN1 NUP98 LAMA3 SIK3 LCP2 KANSL1 ATF7IP ARID2 ANKRD17 MACF1 TXLNG GAB1 | 5.90e-10 | 486 | 201 | 18 | 20936779 | |
| Pubmed | AURKA BSG PLEKHA5 BOD1L1 CAMSAP1 DHX29 AP3D1 CAP1 TTC28 KTN1 LARP1 MAGI3 SHTN1 PDLIM5 TLN1 ANKRD17 MACF1 MARK2 SEPTIN7 PATJ GAB1 | 1.14e-09 | 708 | 201 | 21 | 39231216 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 CYTH1 MTG2 ZZEF1 LYST PRR12 URB1 TULP4 CAMSAP1 PREX1 AP3D1 EPN3 SEMA7A DOCK9 NSD1 ARFGEF2 MED13L HDAC7 SYNE4 ARHGEF10L KANSL1 CSNK1G2 TTLL4 TLN1 MARK4 ELL | 1.48e-09 | 1105 | 201 | 26 | 35748872 |
| Pubmed | PDLIM7 CYTH1 BCOR AURKA PRR12 URB1 HEATR5B DHX29 PREX1 PDLIM2 INTS12 KTN1 PPP1R9A NSD1 DIDO1 DGKZ ATAD2 SPECC1 ARPC5 DICER1 PCF11 CEBPZ CSNK1G2 ARID2 TLN1 ANKRD17 UNK MACF1 MARK2 PATJ | 3.07e-09 | 1497 | 201 | 30 | 31527615 | |
| Pubmed | NCOA6 PDLIM7 BCOR GTF3C5 PLEKHA5 BOD1L1 TTC28 KTN1 NSD1 LARP1 DIDO1 SHTN1 PDLIM5 CEBPZ ARID2 TLN1 SMARCA4 PATJ | 4.00e-09 | 549 | 201 | 18 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 RSL1D1 BCOR USP42 DHX29 GIT1 EML4 NUP98 ARFGEF2 LARP1 DIDO1 IQCN ATAD2 HDAC7 PCF11 KANSL1 SMARCA4 ANKRD17 UNK MARK2 SRRM2 | 5.47e-09 | 774 | 201 | 21 | 15302935 |
| Pubmed | PDLIM7 ARHGEF16 GTF3C5 DHX29 CAP1 TTC28 LARP1 SHTN1 PDLIM5 TLN1 ANKRD17 SEPTIN7 | 5.63e-09 | 216 | 201 | 12 | 31519766 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDK8 MAP2 CDK14 ARHGEF16 TULP4 GPR158 TBC1D14 BOD1L1 USP53 SOBP WWP2 PPP1R9A LAMA3 LARP1 RNF213 MAGI3 PARD3B IQCN SHTN1 ARPC5 DNAH1 MSRA ZNF532 MBNL2 ANKRD17 MACF1 PNPLA7 PATJ PDZD2 | 1.09e-08 | 1489 | 201 | 29 | 28611215 |
| Pubmed | CDK8 NCOA6 PDLIM7 TULP4 BSG GLUD1 CAP1 TCF7 CAMK2D WWP2 KTN1 NUP98 LARP1 SAE1 MED13L SPECC1 HDAC7 PDLIM5 DNAH1 CEBPZ TLN1 ANKRD17 MARK2 SEPTIN7 PATJ SRRM2 | 1.75e-08 | 1247 | 201 | 26 | 27684187 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TET2 MAPKAPK3 PLEKHA5 TACC2 MED13L DICER1 SLC25A51 PPM1A VPS13D KANSL1 MBNL2 CSNK1G2 ARID2 TTLL4 SLC25A52 KDM4A MARK2 | 1.79e-08 | 536 | 201 | 17 | 15840001 |
| Pubmed | TET2 MAPKAPK3 PLEKHA5 TACC2 MED13L DICER1 SLC25A51 PPM1A VPS13D KANSL1 MBNL2 CSNK1G2 ARID2 TTLL4 SLC25A52 KDM4A MARK2 | 1.89e-08 | 538 | 201 | 17 | 10512203 | |
| Pubmed | TET2 BCOR GTF3C5 PRR12 SALL1 PLEKHA5 CAMSAP1 GPRASP2 TTC28 CAMK2G POLH SHTN1 ZNF532 ATF7IP ANKRD17 | 2.55e-08 | 418 | 201 | 15 | 34709266 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TBC1D2B GIT2 BCOR COPS7A SALL1 ASPM INTS12 TTC28 GIT1 TACC2 ATF7IP ARID2 UNK MACF1 ERC2 PATJ GAB1 | 6.79e-08 | 588 | 201 | 17 | 38580884 |
| Pubmed | ERCC4 RSL1D1 BCOR COPS7A AURKA URB1 PGAP1 BOD1L1 CPLANE1 TICRR CAMK2D DOCK9 NSD1 DIDO1 DGKZ TACC2 FAM171B NCOA4 ARPC5 TTLL4 ANKRD17 MACF1 PATJ | 9.14e-08 | 1084 | 201 | 23 | 11544199 | |
| Pubmed | CDK8 TET2 NCOA6 RSL1D1 BCOR AURKA PRR12 NFIL3 CAP1 INTS12 EBF3 CAMK2G LARP1 SAE1 DIDO1 MED13L PCF11 POLR1D ARID2 TLN1 SMARCA4 SRRM2 TXLNG | 1.24e-07 | 1103 | 201 | 23 | 34189442 | |
| Pubmed | TET2 RSL1D1 CYTH1 TTC7B GLUD1 PREX1 GPRASP2 RBFOX3 TTC28 GIT1 ARFGEF2 MAGI3 MED13L SHTN1 SPECC1 PDLIM5 CLIP4 ZNF532 WIF1 SMARCA4 MACF1 ERC2 KDM4A SEPTIN7 TXLNG | 1.26e-07 | 1285 | 201 | 25 | 35914814 | |
| Pubmed | 1.38e-07 | 101 | 201 | 8 | 10997877 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 RSL1D1 BCOR SALL1 BOD1L1 EML4 POLH KTN1 NUP98 NSD1 LARP1 DIDO1 PCF11 MBNL2 CEBPZ ATF7IP ARID2 SMARCA4 SEPTIN7 SRRM2 ELL | 1.89e-07 | 954 | 201 | 21 | 36373674 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | MAP2 RSL1D1 EXPH5 TBC1D2B COPS7A BSG PLEKHA5 AP3D1 DOCK9 KTN1 LCP2 VPS13D ARID2 KDM4A MARK2 | 2.39e-07 | 497 | 201 | 15 | 36774506 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 PDLIM7 ZNF469 SALL1 TULP4 CAMSAP1 USP53 NUP98 ZNF532 ARID2 TLN1 UNK PATJ GAB1 | 2.46e-07 | 430 | 201 | 14 | 35044719 |
| Pubmed | MAP2 TTC7B SLC24A2 GLUD1 GLUD2 PLEKHA5 DHX29 AP3D1 CAP1 GIT1 CAMK2D CAMK2G KTN1 PPP1R9A ARFGEF2 LARP1 DGKZ SPECC1 ARPC5 PDLIM5 TLN1 SMARCA4 MACF1 ERC2 MARK2 SEPTIN7 | 2.59e-07 | 1431 | 201 | 26 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 RSL1D1 PDLIM7 GTF3C5 URB1 ASPM PLEKHA5 DHX29 AP3D1 CAP1 EML4 CAMK2D CAMK2G KTN1 SAE1 ATAD2 ACTR1B POLR1D KANSL1 CEBPZ TLN1 SMARCA4 ANKRD17 MACF1 SRRM2 | 3.30e-07 | 1353 | 201 | 25 | 29467282 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | PDLIM7 ASPM PLEKHA5 AP3D1 POLH NUP98 LARP1 DIDO1 SHTN1 TLN1 ANKRD17 | 3.32e-07 | 256 | 201 | 11 | 33397691 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DCAF1 COPS7A USP42 BSG GPRASP2 USP53 TTC28 CAMK2D CAMK2G KTN1 PPP1R9A NUP98 MAGI3 ARPC5 DICER1 MARK4 ANKRD17 KDM4A MARK2 SRRM2 ELL | 4.40e-07 | 1005 | 201 | 21 | 19615732 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RSL1D1 GTF3C5 URB1 ASPM DHX29 AP3D1 TICRR KTN1 LARP1 DIDO1 TACC2 CEBPZ ARID2 SMARCA4 MACF1 ERC2 MARK2 TXLNG | 5.12e-07 | 759 | 201 | 18 | 35915203 |
| Pubmed | DCAF1 MAP2 RSL1D1 URB1 COCH BSG GLUD1 ASPM PLEKHA5 DHX29 AP3D1 WWP2 KTN1 SIK3 TRAPPC8 DICER1 PCF11 FAM171A2 CEP89 CEBPZ TLN1 MACF1 MARK2 SRRM2 TXLNG GAB1 | 5.36e-07 | 1487 | 201 | 26 | 33957083 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RSL1D1 BCOR GLUD1 BOD1L1 CAMSAP1 DHX29 AP3D1 KTN1 NUP98 LARP1 DIDO1 TACC2 SHTN1 PDLIM5 ATF7IP ARID2 TLN1 SMARCA4 ANKRD17 MACF1 | 5.77e-07 | 934 | 201 | 20 | 33916271 |
| Pubmed | Regulatory T cells require TCR signaling for their suppressive function. | 7.57e-07 | 4 | 201 | 3 | 25821220 | |
| Pubmed | Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection. | 7.57e-07 | 4 | 201 | 3 | 12139918 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | RSL1D1 PRR12 TTC7B GPR158 DHX29 AP3D1 RBFOX3 SEMA7A GIT1 CAMK2D MAGI3 SCUBE1 KANSL1 UNK | 8.08e-07 | 475 | 201 | 14 | 31040226 |
| Pubmed | DCAF1 BOD1L1 TTC28 DOCK9 PPP1R9A MED13L KANSL1 TLN1 MARK4 MACF1 ERC2 SRRM2 PDZD2 | 8.29e-07 | 407 | 201 | 13 | 12693553 | |
| Pubmed | MAP2 GPR158 BSG GLUD1 GLUD2 CAMSAP1 DHX29 CAP1 NYAP2 GIT1 CAMK2D CAMK2G DOCK9 KTN1 TACC2 FAM171B SLC25A51 FAM171A2 UBR3 MACF1 SLC25A52 SEPTIN7 | 8.56e-07 | 1139 | 201 | 22 | 36417873 | |
| Pubmed | TET2 NCOA6 ERCC4 INO80C RSL1D1 BCOR PRR12 SALL1 BSG GLUD1 TCF7 INTS12 SOBP POLH NUP98 LARP1 DIDO1 PCF11 KANSL1 ATF7IP ARID2 SMARCA4 ANKRD17 UNK SRRM2 | 8.95e-07 | 1429 | 201 | 25 | 35140242 | |
| Pubmed | RSL1D1 LYST BSG GLUD1 GLUD2 ASPM BOD1L1 TSACC PREX1 AP3D1 ZNF541 SMIM24 INTS12 ABI3BP CAMK2G KTN1 PPP1R9A NUP98 LARP1 MAGI3 ARPC5 PCF11 CEBPZ MACF1 ERC2 | 1.05e-06 | 1442 | 201 | 25 | 35575683 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DCAF1 RSL1D1 PDLIM7 GTF3C5 COPS7A AURKA RTKN2 URB1 BSG FAM107B ASPM NUP98 LARP1 TACC2 SPECC1 PCF11 ACTR1B KANSL1 ARID2 TLN1 SMARCA4 MARK2 | 1.08e-06 | 1155 | 201 | 22 | 20360068 |
| Pubmed | TTC7B BSG PLEKHA5 SASH1 PPP1R9A PARD3B FAM171B SPECC1 FAM171A2 CEP89 MACF1 MARK2 GAB1 | 1.21e-06 | 421 | 201 | 13 | 36976175 | |
| Pubmed | EXPH5 PRR12 TULP4 PREX1 ADAMTS4 KTN1 RNF213 MAGI3 TRAPPC8 PCF11 VPS13D ARID2 UBR3 MACF1 | 1.25e-06 | 493 | 201 | 14 | 15368895 | |
| Pubmed | DCAF1 PLEKHA5 KTN1 PPP1R9A NUP98 LARP1 DIDO1 PDLIM5 TLN1 MACF1 SRRM2 TXLNG | 1.42e-06 | 360 | 201 | 12 | 33111431 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | RSL1D1 SYCP2 COCH MAPKAPK3 PLEKHA5 CAMSAP1 CPLANE1 DIDO1 PCF11 ASXL3 MACF1 SRRM2 | 1.46e-06 | 361 | 201 | 12 | 26167880 |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 1.50e-06 | 186 | 201 | 9 | 33637726 | |
| Pubmed | DCAF1 BCOR CAMSAP1 NSD1 NCOA4 DICER1 PDLIM5 ANKRD17 MARK2 TXLNG | 1.64e-06 | 242 | 201 | 10 | 34011540 | |
| Pubmed | Developmental control of CaV1.2 L-type calcium channel splicing by Fox proteins. | 1.89e-06 | 5 | 201 | 3 | 19564422 | |
| Pubmed | 1.89e-06 | 5 | 201 | 3 | 15261831 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ERCC4 RSL1D1 CAMSAP1 DHX29 GIT1 NUP98 LARP1 DICER1 PCF11 CEBPZ ARID2 SMARCA4 ANKRD17 | 1.96e-06 | 440 | 201 | 13 | 34244565 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | PDLIM7 CAMSAP1 CPLANE1 USP53 TTC28 GIT1 MAGI3 PARD3B SIK3 ARPC5 PDLIM5 PPM1A ACTR1B TLN1 UNK SEPTIN7 TXLNG ELL | 2.67e-06 | 853 | 201 | 18 | 28718761 |
| Pubmed | 3.27e-06 | 153 | 201 | 8 | 10718198 | ||
| Pubmed | DCAF1 RSL1D1 BCOR SALL1 USP42 GLUD1 PCDH15 DHX29 AP3D1 DIDO1 EBF1 SPECC1 | 3.79e-06 | 396 | 201 | 12 | 26687479 | |
| Pubmed | 3.92e-06 | 19 | 201 | 4 | 15334068 | ||
| Pubmed | 4.06e-06 | 268 | 201 | 10 | 33640491 | ||
| Pubmed | NCOA6 BCOR GTF3C5 SALL1 PREX1 TCF7 NYAP2 DRP2 TTC28 CAMK2G KTN1 SIK3 ASXL3 ARID2 ANKRD17 | 5.23e-06 | 638 | 201 | 15 | 31182584 | |
| Pubmed | AIM2 TICRR MAGI3 ABCC9 C16orf96 OR2A5 TACC2 EBF1 SPECC1 PKHD1L1 HDAC7 ARHGEF10L PCF11 MBNL2 RBFOX1 PATJ PDZD2 | 5.85e-06 | 814 | 201 | 17 | 23251661 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RSL1D1 GIT2 CDK14 AURKA BSG ASPM PREX1 GIT1 EBF3 EML4 CAMK2D NUP98 LARP1 SAE1 ARPC5 HDAC7 PPM1A SMARCA4 MARK2 SEPTIN7 SRRM2 ELL | 5.90e-06 | 1284 | 201 | 22 | 17353931 |
| Pubmed | 6.21e-06 | 45 | 201 | 5 | 33596420 | ||
| Pubmed | GTF3C5 PLEKHA5 BOD1L1 CAMSAP1 TTC28 KTN1 LARP1 RNF213 NCOA4 DICER1 PDLIM5 CEBPZ TTLL4 SMARCA4 UNK PATJ | 6.42e-06 | 733 | 201 | 16 | 34672954 | |
| Pubmed | Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. | 6.54e-06 | 7 | 201 | 3 | 24786561 | |
| Pubmed | 6.54e-06 | 7 | 201 | 3 | 34269483 | ||
| Pubmed | RSL1D1 URB1 CAP1 NUP98 NSD1 LARP1 DIDO1 ATAD2 DICER1 CEBPZ TLN1 SMARCA4 ANKRD17 MACF1 SRRM2 | 6.90e-06 | 653 | 201 | 15 | 22586326 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 NCOA6 BCOR PRR12 SALL1 GLUD1 SOBP NUP98 ASXL3 ARID2 SMARCA4 | 7.06e-06 | 351 | 201 | 11 | 38297188 |
| Pubmed | CDK8 DCAF1 INO80C BCOR ZZEF1 ZNF469 ASPM PDLIM2 TTC28 RNF213 C16orf96 SIK3 DICER1 ARSB ARID2 MARK4 SMARCA4 ANKRD17 MACF1 SRRM2 | 8.39e-06 | 1116 | 201 | 20 | 31753913 | |
| Pubmed | 9.74e-06 | 234 | 201 | 9 | 36243803 | ||
| Pubmed | RSL1D1 GTF3C5 PRR12 URB1 KTN1 NUP98 LARP1 ATAD2 ARPC5 PCF11 ACTR1B CEBPZ ARID2 SMARCA4 ANKRD17 SRRM2 ELL | 9.79e-06 | 847 | 201 | 17 | 35850772 | |
| Pubmed | 1.05e-05 | 24 | 201 | 4 | 20826655 | ||
| Pubmed | 1.12e-05 | 130 | 201 | 7 | 12421765 | ||
| Pubmed | Precise temporal regulation of alternative splicing during neural development. | 1.56e-05 | 9 | 201 | 3 | 29875359 | |
| Pubmed | 1.56e-05 | 9 | 201 | 3 | 12176364 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOA6 INO80C RSL1D1 BCOR GTF3C5 AURKA PRR12 URB1 USP42 NFIL3 SLC27A2 TICRR INTS12 KTN1 NUP98 NSD1 DIDO1 KANSL1 CEBPZ SMARCA4 SRRM2 | 2.18e-05 | 1294 | 201 | 21 | 30804502 |
| Pubmed | NCOA6 COPS7A AURKA ASPM PLEKHA5 CAMSAP1 EML4 POLH DIDO1 ARID2 MACF1 SRRM2 | 2.19e-05 | 472 | 201 | 12 | 38943005 | |
| Pubmed | 2.49e-05 | 147 | 201 | 7 | 16959763 | ||
| Pubmed | 2.62e-05 | 100 | 201 | 6 | 26073538 | ||
| Pubmed | ERCC4 ZZEF1 PRR12 PLEKHA5 AP3D1 TTC28 EML4 LARP1 DIDO1 SIK3 DICER1 ANKRD17 MARK2 PATJ | 2.85e-05 | 650 | 201 | 14 | 38777146 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 2.94e-05 | 102 | 201 | 6 | 15778465 | |
| Pubmed | PDLIM7 ARHGEF16 BSG CAMSAP1 DHX29 KTN1 NUP98 LARP1 TRAPPC8 SHTN1 PDLIM5 VPS13D TLN1 | 2.97e-05 | 568 | 201 | 13 | 37774976 | |
| Pubmed | STK11 is required for the normal program of ciliated cell differentiation in airways. | 3.01e-05 | 31 | 201 | 4 | 31636950 | |
| Pubmed | 3.03e-05 | 11 | 201 | 3 | 21491429 | ||
| Pubmed | 3.17e-05 | 209 | 201 | 8 | 36779422 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 34173171 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 28621566 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 23979596 | ||
| Pubmed | Functional association between SLAP-130 and SLP-76 in Jurkat T cells. | 3.32e-05 | 2 | 201 | 2 | 10671560 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 32078638 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 26637799 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 23595828 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 21621574 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 28911206 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 21813447 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 22875990 | ||
| Pubmed | Adipocyte CAMK2 deficiency improves obesity-associated glucose intolerance. | 3.32e-05 | 2 | 201 | 2 | 34303021 | |
| Pubmed | Molecular basis of human glutamate dehydrogenase regulation under changing energy demands. | 3.32e-05 | 2 | 201 | 2 | 15578726 | |
| Pubmed | Important role of Ser443 in different thermal stability of human glutamate dehydrogenase isozymes. | 3.32e-05 | 2 | 201 | 2 | 15044002 | |
| Pubmed | Induction of excitatory and inhibitory presynaptic differentiation by GluD1. | 3.32e-05 | 2 | 201 | 2 | 22138648 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 16598076 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 34220417 | ||
| Pubmed | Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues. | 3.32e-05 | 2 | 201 | 2 | 26241911 | |
| Interaction | YWHAG interactions | TET2 NCOA6 MAP2 EXPH5 CYTH1 GIT2 CDK14 ARHGEF16 LYST PLEKHA5 BOD1L1 CAMSAP1 GPRASP2 USP53 TICRR SASH1 TTC28 GIT1 CAMK2G DOCK9 SH2D3C LARP1 MAGI3 PARD3B SIK3 SHTN1 SPECC1 HDAC7 VPS13D FAM171A2 CEP89 MARK4 ANKRD17 UNK MACF1 MARK2 PATJ SRRM2 GAB1 | 9.68e-11 | 1248 | 198 | 39 | int:YWHAG |
| Interaction | YWHAH interactions | TET2 NCOA6 MAP2 EXPH5 GIT2 CDK14 ARHGEF16 LYST PLEKHA5 BOD1L1 CAMSAP1 USP53 TICRR INTS12 SASH1 TTC28 GIT1 CAMK2G DOCK9 LARP1 MAGI3 PARD3B SIK3 SHTN1 SPECC1 HDAC7 VPS13D FAM171A2 CEP89 MARK4 ANKRD17 MACF1 MARK2 PATJ SRRM2 GAB1 | 1.73e-10 | 1102 | 198 | 36 | int:YWHAH |
| Interaction | YWHAE interactions | DCAF1 TET2 PDLIM7 EXPH5 GIT2 TCEANC CDK14 ARHGEF16 LYST PLEKHA5 CAMSAP1 EPN3 TICRR SASH1 TTC28 GIT1 CAMK2G WWP2 DOCK9 KTN1 LARP1 SAE1 PARD3B TACC2 SIK3 LCP2 SHTN1 SPECC1 HDAC7 CEP89 MARK4 ANKRD17 UNK MACF1 ERC2 MARK2 SRRM2 GAB1 | 4.43e-10 | 1256 | 198 | 38 | int:YWHAE |
| Interaction | YWHAB interactions | TET2 MAP2 EXPH5 CDK14 ARHGEF16 LYST PLEKHA5 HES1 CAMSAP1 GPRASP2 TICRR SASH1 TTC28 CAMK2G DOCK9 LARP1 PARD3B SIK3 TRAPPC8 SHTN1 SPECC1 HDAC7 PDLIM5 VPS13D FAM171A2 CEP89 MARK4 ANKRD17 UNK MACF1 MARK2 SRRM2 GAB1 | 1.23e-09 | 1014 | 198 | 33 | int:YWHAB |
| Interaction | YWHAZ interactions | TET2 MAP2 EXPH5 BCOR CDK14 ARHGEF16 LYST PLEKHA5 CAMSAP1 TICRR SASH1 TTC28 GIT1 CAMK2D CAMK2G WWP2 DOCK9 SH2D3C LARP1 PARD3B TACC2 SIK3 LCP2 SHTN1 SPECC1 HDAC7 PPM1A VPS13D FAM171A2 CEP89 ASXL3 MARK4 ANKRD17 UNK MACF1 MARK2 GAB1 | 6.07e-09 | 1319 | 198 | 37 | int:YWHAZ |
| Interaction | YWHAQ interactions | TET2 NCOA6 MAP2 EXPH5 CDK14 ARHGEF16 LYST USP42 PLEKHA5 CAMSAP1 BANK1 SLC27A2 TICRR SASH1 TTC28 WWP2 LARP1 PARD3B SIK3 SHTN1 SPECC1 HDAC7 PPM1A VPS13D FAM171A2 CEP89 TLN1 ANKRD17 MACF1 MARK2 GAB1 | 1.61e-07 | 1118 | 198 | 31 | int:YWHAQ |
| Interaction | SFN interactions | TET2 NCOA6 MAP2 EXPH5 ARHGEF16 LYST PLEKHA5 CAMSAP1 USP53 SASH1 LARP1 PARD3B SIK3 SHTN1 SPECC1 HDAC7 FAM171A2 CEP89 ANKRD17 MACF1 MARK2 SRRM2 GAB1 | 3.51e-07 | 692 | 198 | 23 | int:SFN |
| Interaction | MAPRE1 interactions | MAP2 ARHGEF16 COPS7A AURKA BSG PLEKHA5 CAMSAP1 EML4 CAMK2G KTN1 NUP98 LARP1 TACC2 SPECC1 ARPC5 ACTR1B UNK MACF1 SRRM2 | 8.20e-07 | 514 | 198 | 19 | int:MAPRE1 |
| Interaction | KCNA3 interactions | EXPH5 AURKA BSG PLEKHA5 BOD1L1 CAMSAP1 DHX29 AP3D1 CAP1 TTC28 KTN1 LARP1 RNF213 MAGI3 SHTN1 SPECC1 PDLIM5 TLN1 SMARCA4 ANKRD17 MACF1 MARK2 SEPTIN7 PATJ GAB1 | 1.57e-06 | 871 | 198 | 25 | int:KCNA3 |
| Interaction | CDH1 interactions | CDK8 RSL1D1 PDLIM7 ARHGEF16 BSG PLEKHA5 DHX29 EPN3 DOCK9 KTN1 LARP1 MAGI3 C16orf96 FAM171B SHTN1 SPECC1 PDLIM5 TLN1 MACF1 MARK2 SEPTIN7 PATJ GAB1 | 2.09e-06 | 768 | 198 | 23 | int:CDH1 |
| Interaction | TOP3B interactions | NCOA6 CYTH1 MTG2 ZZEF1 LYST PRR12 ANOS1 URB1 TULP4 CAMSAP1 PREX1 AP3D1 EPN3 SEMA7A DOCK9 KTN1 PPP1R9A NSD1 ARFGEF2 MED13L HDAC7 SYNE4 ARHGEF10L ACTR1B KANSL1 CSNK1G2 TTLL4 TLN1 MARK4 ANKRD17 UNK KDM4A TXLNG ELL | 2.46e-06 | 1470 | 198 | 34 | int:TOP3B |
| Interaction | RAC3 interactions | RSL1D1 TBC1D2B GIT2 BSG GLUD2 PLEKHA5 GIT1 WWP2 DOCK9 KTN1 PPP1R9A FAM171B SHTN1 SPECC1 HDAC7 FAM171A2 CEP89 MACF1 MARK2 GAB1 | 3.28e-06 | 619 | 198 | 20 | int:RAC3 |
| Interaction | MED4 interactions | CDK8 RSL1D1 GIT2 GLUD2 CAMSAP1 TTC28 GIT1 WWP2 MED13L SHTN1 PDLIM5 POLR1D CEP89 ATF7IP TLN1 TXLNG | 1.02e-05 | 450 | 198 | 16 | int:MED4 |
| Interaction | NUP43 interactions | DCAF1 NCOA6 RSL1D1 BCOR BOD1L1 POLH NUP98 NSD1 LARP1 ATAD2 PPM1A KANSL1 ZNF532 CEBPZ ATF7IP ARID2 SMARCA4 SRRM2 PDZD2 | 1.38e-05 | 625 | 198 | 19 | int:NUP43 |
| Interaction | WWTR1 interactions | NCOA6 PDLIM7 BCOR PLEKHA5 TTC28 KTN1 LARP1 DIDO1 SHTN1 PDLIM5 CEBPZ ARID2 TLN1 SMARCA4 PATJ | 1.95e-05 | 422 | 198 | 15 | int:WWTR1 |
| Interaction | EBF4 interactions | 3.18e-05 | 7 | 198 | 3 | int:EBF4 | |
| Interaction | MAD2L1 interactions | ERCC4 AURKA PRR12 BSG BOD1L1 PPP1R9A NUP98 ATF7IP MACF1 ELL GAB1 | 4.17e-05 | 252 | 198 | 11 | int:MAD2L1 |
| Interaction | RHOJ interactions | RSL1D1 GIT2 AURKA BSG PLEKHA5 GIT1 WWP2 DOCK9 PPP1R9A ARFGEF2 FAM171B SPECC1 FAM171A2 CEP89 CSNK1G2 MACF1 MARK2 GAB1 | 5.59e-05 | 633 | 198 | 18 | int:RHOJ |
| Interaction | C2CD4B interactions | 6.92e-05 | 44 | 198 | 5 | int:C2CD4B | |
| Interaction | EPB41L4A interactions | 7.44e-05 | 140 | 198 | 8 | int:EPB41L4A | |
| Interaction | RHOB interactions | RSL1D1 TBC1D2B ARHGEF16 AURKA RTKN2 TTC7B BSG PLEKHA5 WWP2 DOCK9 PPP1R9A PARD3B FAM171B SPECC1 FAM171A2 CEP89 MACF1 MARK2 SEPTIN7 PATJ GAB1 | 8.49e-05 | 840 | 198 | 21 | int:RHOB |
| Interaction | TRIM36 interactions | 9.07e-05 | 144 | 198 | 8 | int:TRIM36 | |
| Interaction | MAPRE3 interactions | MAP2 AURKA PLEKHA5 CAMSAP1 TTC28 EML4 TACC2 SPECC1 MACF1 MARK2 | 9.64e-05 | 230 | 198 | 10 | int:MAPRE3 |
| Interaction | HRAS interactions | EXPH5 CDK14 ARHGEF16 USP42 BSG PLEKHA5 CAMSAP1 EPN3 USP53 TTC28 DOCK9 ARFGEF2 DGKZ ATAD2 SPECC1 MARK2 SEPTIN7 PATJ GAB1 | 1.02e-04 | 725 | 198 | 19 | int:HRAS |
| Interaction | PHLPP1 interactions | PDLIM7 ASPM PLEKHA5 AP3D1 POLH NUP98 LARP1 DIDO1 SHTN1 TLN1 ANKRD17 MARK2 | 1.18e-04 | 333 | 198 | 12 | int:PHLPP1 |
| Interaction | RHOQ interactions | RSL1D1 GIT2 BSG GLUD1 PLEKHA5 GIT1 WWP2 DOCK9 PPP1R9A SPECC1 FAM171A2 CEP89 MARK2 GAB1 | 1.27e-04 | 442 | 198 | 14 | int:RHOQ |
| Interaction | HDAC4 interactions | RSL1D1 BCOR PRR12 TTC7B GPR158 BSG DHX29 AP3D1 RBFOX3 SEMA7A CAMK2D SAE1 MAGI3 HDAC7 PDLIM5 SCUBE1 KANSL1 UNK MARK2 | 1.43e-04 | 744 | 198 | 19 | int:HDAC4 |
| Interaction | SOX7 interactions | 1.57e-04 | 82 | 198 | 6 | int:SOX7 | |
| Interaction | CNTNAP2 interactions | 1.73e-04 | 158 | 198 | 8 | int:CNTNAP2 | |
| Interaction | NINL interactions | PDLIM7 TCEANC CAMSAP1 CAP1 USP53 TTC28 GIT1 CAMK2D CAMK2G DNAH1 ACTR1B KANSL1 CEP89 TXLNG | 1.83e-04 | 458 | 198 | 14 | int:NINL |
| Interaction | HSP90AB1 interactions | DCAF1 TET2 COPS7A AURKA BMX BSG BOD1L1 ZNF541 CAP1 WWP2 POLH KTN1 LAMA3 MAGI3 SIK3 DICER1 POLR1D CSNK1G2 ASXL3 TLN1 UNK MARK2 | 1.99e-04 | 960 | 198 | 22 | int:HSP90AB1 |
| GeneFamily | PDZ domain containing | 1.03e-06 | 152 | 124 | 9 | 1220 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.82e-05 | 206 | 124 | 8 | 682 | |
| GeneFamily | WD repeat domain containing|Xeroderma pigmentosum complementation groups|Nucleotide excision repair | 1.27e-03 | 8 | 124 | 2 | 1125 | |
| GeneFamily | Ankyrin repeat domain containing | 1.41e-03 | 242 | 124 | 7 | 403 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CYTH1 TBC1D2B GIT2 LYST USP42 BOD1L1 PREX1 PDLIM2 CAP1 TCF7 EML4 DOCK9 KTN1 SH2D3C NUP98 NSD1 RNF213 SIK3 TRAPPC8 LCP2 ARPC5 DICER1 PPM1A PCF11 KANSL1 CSNK1G2 ATF7IP ARID2 TLN1 MACF1 SEPTIN7 FYB1 ELL | 3.87e-08 | 1492 | 201 | 33 | M40023 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MAP2 CYTH1 TBC1D2B LYST TULP4 GPR158 SLC24A2 LRFN5 PGAP1 BOD1L1 RBFOX3 EBF3 SOBP PPP1R9A VSTM2A LAMA3 MAGI3 EBF1 SIK3 MED13L FAM171B SHTN1 DICER1 CSNK1G2 ASXL3 RBFOX1 ERC2 | 1.12e-07 | 1106 | 201 | 27 | M39071 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | TBC1D2B LYST SEMA7A ARFGEF2 LCP2 DICER1 MBNL2 ARID2 SMARCA4 INSYN2B | 3.96e-07 | 157 | 201 | 10 | M7733 |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | SPATA3 CDK14 ZZEF1 AP3D1 EPN3 EML4 CAMK2D WWP2 DIDO1 EBF1 ARPC5 DICER1 POLR1D ARSB ANKRD17 RASL11B PNPLA7 MARK2 ELL | 6.47e-07 | 646 | 201 | 19 | M2419 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | CDK14 PLEKHA5 SASH1 TTC28 PPP1R9A RNF213 PARD3B PDLIM5 KANSL1 PATJ | 1.13e-06 | 176 | 201 | 10 | M39223 |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP | NCOA6 MTG2 TBC1D2B USP42 SEMA7A MAGI3 TACC2 HDAC7 MBNL2 ARID2 | 1.13e-06 | 176 | 201 | 10 | M7725 |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | SPATA3 CDK14 ZZEF1 AP3D1 EPN3 EML4 CAMK2D WWP2 DIDO1 EBF1 ARPC5 DICER1 POLR1D ARSB ANKRD17 RASL11B PNPLA7 MARK2 ELL | 1.24e-06 | 675 | 201 | 19 | MM1073 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.39e-06 | 180 | 201 | 10 | M8239 | |
| Coexpression | GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | ERCC4 PDLIM7 CDK14 NFIL3 HEATR5B PREX1 WWP2 POLH SHTN1 VPS13D | 3.42e-06 | 199 | 201 | 10 | M313 |
| Coexpression | GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN | 6.98e-06 | 170 | 201 | 9 | M2942 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 2.46e-05 | 199 | 201 | 9 | M6964 | |
| Coexpression | KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN | 2.56e-05 | 200 | 201 | 9 | M3032 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 3.13e-05 | 158 | 201 | 8 | M372 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_2_DN | 3.61e-05 | 9 | 201 | 3 | M2163 | |
| Coexpression | CHANDRAN_METASTASIS_UP | 3.61e-05 | 209 | 201 | 9 | M16036 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | RSL1D1 TBC1D2B GIT2 BCOR CDK14 ZZEF1 PREX1 CAP1 SASH1 MED13L CEBPZ ATF7IP RBFOX1 | 3.93e-05 | 441 | 201 | 13 | M172 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 4.03e-05 | 212 | 201 | 9 | M39221 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TET2 ERCC4 PDLIM7 CYTH1 CA14 TULP4 TBC1D14 PDLIM2 EBF4 USP53 SASH1 ADAMTS4 CAMK2D WWP2 DOCK9 SAE1 PELI1 SPECC1 ARSB KANSL1 MBNL2 GAB1 | 4.20e-05 | 1102 | 201 | 22 | M2369 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 4.46e-05 | 166 | 201 | 8 | M8129 | |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 4.46e-05 | 166 | 201 | 8 | M7722 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | CYTH1 TULP4 HES1 GPRASP2 SASH1 SOBP NSD1 RNF213 PELI1 SIK3 MED13L DICER1 PDLIM5 KANSL1 ATF7IP ARID2 PATJ SRRM2 | 5.41e-05 | 807 | 201 | 18 | M16651 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TET2 ERCC4 PDLIM7 CYTH1 CA14 TULP4 TBC1D14 PDLIM2 EBF4 USP53 SASH1 ADAMTS4 CAMK2D WWP2 DOCK9 SAE1 PELI1 SPECC1 ARSB KANSL1 MBNL2 GAB1 | 5.63e-05 | 1124 | 201 | 22 | MM1070 |
| Coexpression | GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN | 6.47e-05 | 175 | 201 | 8 | M2940 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_483_5P_GENES | 7.01e-05 | 11 | 201 | 3 | MM17503 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | CYTH1 BCOR PCDH15 PLEKHA5 AP3D1 SMIM24 LARP1 MSRA CYP2R1 MARK2 SRRM2 PDZD2 | 9.80e-05 | 417 | 201 | 12 | M39224 |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | PDLIM7 PLEKHA5 HES1 PDLIM2 SASH1 SH2D3C ABCC9 EBF1 SEPTIN7 PDZD2 | 1.25e-04 | 303 | 201 | 10 | M39040 |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP | 1.33e-04 | 145 | 201 | 7 | M3045 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN | 1.37e-04 | 195 | 201 | 8 | M9808 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE | 1.37e-04 | 195 | 201 | 8 | M45684 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | TBC1D2B SYCP2 HES1 PDLIM2 SASH1 ADAMTS4 CAMK2D SH2D3C RNF213 ABCC9 EBF1 LCP2 SPECC1 TLN1 SEPTIN7 GAB1 PDZD2 | 1.45e-04 | 795 | 201 | 17 | M39050 |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 1.53e-04 | 198 | 201 | 8 | M4451 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN | 1.63e-04 | 36 | 201 | 4 | M13327 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 1.63e-04 | 200 | 201 | 8 | M9439 | |
| Coexpression | GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 1.63e-04 | 200 | 201 | 8 | M309 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 1.63e-04 | 200 | 201 | 8 | M6477 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP | 1.63e-04 | 200 | 201 | 8 | M6668 | |
| Coexpression | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN | 1.70e-04 | 106 | 201 | 6 | M9160 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | ANOS1 SYCP2 PREX1 EPN3 USP53 SASH1 CAMK2G DIDO1 TACC2 EBF1 FAM171B RASL11B GAB1 PDZD2 | 1.76e-04 | 583 | 201 | 14 | M17454 |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 2.01e-04 | 155 | 201 | 7 | M39246 | |
| Coexpression | FAN_EMBRYONIC_CTX_OLIG | KCTD8 CA14 BCOR TULP4 SLC24A2 FAM107B PREX1 ADAMTS4 DOCK9 KTN1 PELI1 SIK3 SHTN1 ARPC5 MBNL2 GAB1 | 2.49e-04 | 754 | 201 | 16 | M39037 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | MAP2 CA14 SALL1 PCDH15 SEMA4A GPRASP2 SLC27A2 EBF4 ABI3BP EBF3 SOBP POLH VSTM2A RNF213 LCP2 SHTN1 SYNE4 ARSB WIF1 SMARCA4 MACF1 RASL11B PATJ FYB1 | 1.17e-05 | 984 | 194 | 24 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_1000 | GIT2 FAM107B HES1 AIM2 PREX1 SASH1 SEMA7A TTC28 EBF3 DOCK9 SH2D3C MAGI3 DGKZ EBF1 LCP2 ARPC5 HDAC7 PDLIM5 MBNL2 MARK4 FYB1 | 1.99e-05 | 817 | 194 | 21 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | MAP2 SALL1 TTC7B ASPM PLEKHA5 CPLANE1 EBF3 VSTM2A NSD1 ARFGEF2 PELI1 EBF1 FAM171B SHTN1 PDLIM5 CLIP4 KANSL1 ASXL3 RBFOX1 WIF1 ERC2 | 2.03e-05 | 818 | 194 | 21 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.88e-05 | 183 | 194 | 9 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | RSL1D1 CA14 SALL1 MAPKAPK3 PCDH15 HES1 SEMA4A GPRASP2 EBF4 RBFOX3 ABI3BP KTN1 VSTM2A RNF213 LCP2 SHTN1 SYNE4 SCUBE1 ARSB BARHL2 WIF1 FYB1 | 8.93e-05 | 976 | 194 | 22 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | CA14 MAPKAPK3 PCDH15 BOD1L1 SEMA4A TSACC GPRASP2 EBF4 MAP3K19 ABI3BP EBF3 SOBP VSTM2A ARFGEF2 RNF213 LCP2 SYNE4 ARSB ASXL3 WIF1 MACF1 FYB1 | 9.20e-05 | 978 | 194 | 22 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | MAP2 EXPH5 RTKN2 ANOS1 PPP1R9A LAMA3 MAGI3 PARD3B TACC2 ERC2 PATJ PDZD2 | 3.89e-11 | 179 | 202 | 12 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e |
| ToppCell | Control|World / group, cell type (main and fine annotations) | EXPH5 RTKN2 PPP1R9A LAMA3 MAGI3 PARD3B TACC2 IQCN WIF1 PATJ PDZD2 | 3.32e-10 | 168 | 202 | 11 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.23e-08 | 183 | 202 | 10 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.29e-08 | 184 | 202 | 10 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.51e-08 | 187 | 202 | 10 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP2 PCDH15 PREX1 SEMA7A ABI3BP TTC28 DOCK9 SH2D3C EBF1 SPECC1 | 1.59e-08 | 188 | 202 | 10 | c2c51c6526defe2600302901159b8abbb58d7595 |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | PLEKHA5 TTC28 EML4 PPP1R9A MAGI3 PARD3B MED13L KANSL1 ARID2 SRRM2 | 1.94e-08 | 192 | 202 | 10 | 916fbec1c7ab7969bda711886ac88e877e30c280 |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | CDK14 PLEKHA5 TTC28 PARD3B SIK3 MED13L ANKRD17 MACF1 PATJ PDZD2 | 1.94e-08 | 192 | 202 | 10 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | PLEKHA5 SOBP PPP1R9A ARFGEF2 MAGI3 DIDO1 PARD3B ATAD2 ARHGEF10L PATJ | 2.04e-08 | 193 | 202 | 10 | 503a979328c68b096680b71359a26f02fafdff35 |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | PLEKHA5 TTC28 EML4 PPP1R9A MAGI3 PARD3B MED13L KANSL1 ARID2 SRRM2 | 2.04e-08 | 193 | 202 | 10 | e6a688bc834f845ff64dae1be64f073eec5091a1 |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | EXPH5 RTKN2 PPP1R9A LAMA3 MAGI3 PARD3B TACC2 WIF1 PATJ PDZD2 | 2.24e-08 | 195 | 202 | 10 | 9406866f99555198a9be311fbd65751b70f35446 |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | ANKUB1 TTC28 PPP1R9A MAGI3 PARD3B SIK3 MED13L KANSL1 GAB1 PDZD2 | 2.36e-08 | 196 | 202 | 10 | ab53c742866945545a92e2e61850d63c80d9a2a6 |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | TTC28 CAMK2D PPP1R9A MAGI3 PARD3B SIK3 MED13L KANSL1 GAB1 PDZD2 | 2.59e-08 | 198 | 202 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-07 | 179 | 202 | 9 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-07 | 180 | 202 | 9 | 551b8de8d933d11bcd3897aeb2fd033355f958e2 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-07 | 181 | 202 | 9 | b193f3606554adc55c5906219d114288bb1f978a | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.64e-07 | 183 | 202 | 9 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.72e-07 | 184 | 202 | 9 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.72e-07 | 184 | 202 | 9 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.80e-07 | 185 | 202 | 9 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.06e-07 | 188 | 202 | 9 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.36e-07 | 191 | 202 | 9 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.36e-07 | 191 | 202 | 9 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.47e-07 | 192 | 202 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.69e-07 | 194 | 202 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-07 | 194 | 202 | 9 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-07 | 194 | 202 | 9 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-07 | 194 | 202 | 9 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-07 | 195 | 202 | 9 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 3.20e-07 | 198 | 202 | 9 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.20e-07 | 198 | 202 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.48e-07 | 200 | 202 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-07 | 164 | 202 | 8 | f9a2cc12179d5621c9174ec01d7418a71edd28d1 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.08e-06 | 169 | 202 | 8 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.13e-06 | 170 | 202 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 183 | 202 | 8 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-06 | 183 | 202 | 8 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 183 | 202 | 8 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.04e-06 | 184 | 202 | 8 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.13e-06 | 185 | 202 | 8 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.21e-06 | 186 | 202 | 8 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.30e-06 | 187 | 202 | 8 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.40e-06 | 188 | 202 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.40e-06 | 188 | 202 | 8 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 2.49e-06 | 189 | 202 | 8 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.49e-06 | 189 | 202 | 8 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.49e-06 | 189 | 202 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 189 | 202 | 8 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.59e-06 | 190 | 202 | 8 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | T_cells-Effector_memory_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.59e-06 | 190 | 202 | 8 | 13dc3a0aaa554f63eabac37726bd1f11b66fb3dd | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.70e-06 | 191 | 202 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.70e-06 | 191 | 202 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.80e-06 | 192 | 202 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.80e-06 | 192 | 202 | 8 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.80e-06 | 192 | 202 | 8 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.91e-06 | 193 | 202 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.91e-06 | 193 | 202 | 8 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | severe-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.03e-06 | 194 | 202 | 8 | 2fee6083fb56b16d1f04fd0b92ec622fd26ba3fa | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-06 | 195 | 202 | 8 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 195 | 202 | 8 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | severe-B_cell|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.15e-06 | 195 | 202 | 8 | 0fc3c605609c9e6bdea15d73c45def2188ae5fb1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-06 | 196 | 202 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-06 | 196 | 202 | 8 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.39e-06 | 197 | 202 | 8 | c842d169dfce9af3ed7c01dc7e940c0bdd21388c | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.39e-06 | 197 | 202 | 8 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.39e-06 | 197 | 202 | 8 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 3.52e-06 | 198 | 202 | 8 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.52e-06 | 198 | 202 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.52e-06 | 198 | 202 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.52e-06 | 198 | 202 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.52e-06 | 198 | 202 | 8 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-06 | 199 | 202 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | mild-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.65e-06 | 199 | 202 | 8 | e6ac9a0959b0de2c6a99298feb7715aa80ade1dd | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.65e-06 | 199 | 202 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.79e-06 | 200 | 202 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.79e-06 | 200 | 202 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 154 | 202 | 7 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 156 | 202 | 7 | 3f0b9e35d4da85c90759b930052e5b9c3cde9b15 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 156 | 202 | 7 | 69e6e8810d1738a66c9821910f41498931cf30cc | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.97e-06 | 158 | 202 | 7 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-06 | 162 | 202 | 7 | 484ea4ac40de672dcbd2583a52cb7f385c918814 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-06 | 162 | 202 | 7 | bba144ac5332bab9eba2ccf599703c781a7f88f1 | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.10e-05 | 166 | 202 | 7 | 30a180b67572c3f4fb3a291f271f855e1b20005e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 1.44e-05 | 173 | 202 | 7 | 67f0f0bf88eab69987b71d96b864ed2b14975adb | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-05 | 173 | 202 | 7 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.44e-05 | 173 | 202 | 7 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-05 | 174 | 202 | 7 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 174 | 202 | 7 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.49e-05 | 174 | 202 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.55e-05 | 175 | 202 | 7 | 69ed3c7c45df6bef70f5f2ff003531160bf3b32b | |
| ToppCell | severe-B_memory|World / disease stage, cell group and cell class | 1.61e-05 | 176 | 202 | 7 | 4e5c6b1aa5ffd13593a6bcd1e1253c1737c5c2b4 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.67e-05 | 177 | 202 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-05 | 179 | 202 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 181 | 202 | 7 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.92e-05 | 181 | 202 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 182 | 202 | 7 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 182 | 202 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 1.99e-05 | 182 | 202 | 7 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-immature_B_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-05 | 182 | 202 | 7 | ab78df9de3878a6d67106a40094c893601de8076 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 182 | 202 | 7 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| Drug | Monobenzone [103-16-2]; Down 200; 20uM; MCF7; HT_HG-U133A | PDLIM7 EXPH5 CYTH1 AURKA ASPM SEMA7A PDLIM5 CLIP4 VPS13D SRRM2 | 5.85e-06 | 186 | 199 | 10 | 3391_DN |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | ERCC4 TBC1D2B DNAAF11 SYCP2 EML4 PCF11 VPS13D MARK4 PATJ ELL | 7.74e-06 | 192 | 199 | 10 | 3318_DN |
| Drug | Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 8.87e-06 | 195 | 199 | 10 | 3288_DN | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A | DCAF1 CAMSAP1 SEMA7A CAMK2G PPP1R9A PDLIM5 CYP2R1 MARK4 RASL11B ELL | 9.27e-06 | 196 | 199 | 10 | 2798_UP |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | PDLIM7 LYST URB1 COCH MAPKAPK3 TTC28 GIT1 POLH NUP98 SMARCA4 | 9.70e-06 | 197 | 199 | 10 | 6949_DN |
| Drug | Diazoxide [364-98-7]; Up 200; 17.4uM; PC3; HT_HG-U133A | 1.06e-05 | 199 | 199 | 10 | 5810_UP | |
| Disease | cortical thickness | ZNF469 COCH FAM107B BANK1 NYAP2 DOCK9 ARFGEF2 ABCC9 TACC2 EBF1 SHTN1 SPECC1 ARPC5 MSRA ACTR1B POLR1D VPS13D SCUBE1 KANSL1 MACF1 ERC2 RASL11B ELL PDZD2 | 2.90e-07 | 1113 | 192 | 24 | EFO_0004840 |
| Disease | executive function measurement | TET2 ERCC4 COCH SLC24A2 PCDH15 PREX1 VSTM2A ARFGEF2 ARHGEF10L POLR1D BARHL2 RBFOX1 | 7.28e-06 | 376 | 192 | 12 | EFO_0009332 |
| Disease | intellectual disability (implicated_via_orthology) | 9.73e-06 | 75 | 192 | 6 | DOID:1059 (implicated_via_orthology) | |
| Disease | forced expiratory volume | TET2 NCOA6 TULP4 PCDH15 PREX1 INTS12 EML4 CAMK2G WWP2 DOCK9 ARFGEF2 LARP1 PARD3B EBF1 KANSL1 TXLNG GAB1 | 1.75e-05 | 789 | 192 | 17 | EFO_0004314 |
| Disease | red blood cell density measurement | TET2 COPS7A SALL1 GLUD1 PREX1 AP3D1 NYAP2 VSTM2A OFCC1 ARFGEF2 SIK3 NCOA4 SPECC1 KANSL1 ARID2 MARK4 KDM4A FYB1 | 1.97e-05 | 880 | 192 | 18 | EFO_0007978 |
| Disease | Albinism | 4.21e-05 | 2 | 192 | 2 | C0001916 | |
| Disease | cancer | TET2 NCOA6 LRRIQ4 PREX1 TCF7 TTC28 EBF1 PDLIM5 ARHGEF10L KANSL1 ERC2 | 6.79e-05 | 400 | 192 | 11 | MONDO_0004992 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | TET2 ERCC4 ANKUB1 CDK14 TULP4 PCDH15 PLEKHA5 NYAP2 TTC28 TACC2 SHTN1 FAM135B BARHL2 RBFOX1 ERC2 ELL | 7.62e-05 | 801 | 192 | 16 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | myocardial infarction | ANKUB1 AP3D1 NYAP2 SASH1 WWP2 DOCK9 MAGI3 PDLIM5 SMARCA4 PDZD2 | 1.07e-04 | 350 | 192 | 10 | EFO_0000612 |
| Disease | myofibrillar myopathy 4 (implicated_via_orthology) | 1.26e-04 | 3 | 192 | 2 | DOID:0080095 (implicated_via_orthology) | |
| Disease | fascioliasis (biomarker_via_orthology) | 1.26e-04 | 3 | 192 | 2 | DOID:885 (biomarker_via_orthology) | |
| Disease | C-reactive protein measurement | NCOA6 KCTD8 ZZEF1 ZNF469 SALL1 PCDH15 AIM2 PDLIM2 BANK1 CAMK2G DGKZ EBF1 MSRA ARSB CSNK1G2 MARK4 SMARCA4 MACF1 PATJ FYB1 | 1.26e-04 | 1206 | 192 | 20 | EFO_0004458 |
| Disease | renal cell carcinoma | 1.60e-04 | 42 | 192 | 4 | EFO_0000681 | |
| Disease | alcohol dependence | 2.05e-04 | 183 | 192 | 7 | MONDO_0007079 | |
| Disease | body weight | TET2 CYTH1 ZZEF1 SPATA31C1 TULP4 SLC24A2 NFIL3 LRFN5 PCDH15 BANK1 INTS12 PARD3B EBF1 SHTN1 MSRA ASXL3 RBFOX1 ERC2 PATJ PDZD2 | 2.26e-04 | 1261 | 192 | 20 | EFO_0004338 |
| Disease | Malignant neoplasm of breast | NCOA6 PDLIM7 AURKA HES1 BOD1L1 ZNF541 POLH KTN1 NUP98 ARFGEF2 TACC2 SIK3 TRAPPC8 HDAC7 SLC25A51 ZNF532 MACF1 GAB1 | 2.44e-04 | 1074 | 192 | 18 | C0006142 |
| Disease | visual impairment and progressive phthisis bulbi (implicated_via_orthology) | 2.51e-04 | 4 | 192 | 2 | DOID:0070356 (implicated_via_orthology) | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 3.17e-04 | 50 | 192 | 4 | EFO_0022247 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.52e-04 | 200 | 192 | 7 | EFO_0004611, EFO_0020945 | |
| Disease | corpus callosum posterior volume measurement | 3.68e-04 | 52 | 192 | 4 | EFO_0010298 | |
| Disease | Adenoid Cystic Carcinoma | 5.06e-04 | 100 | 192 | 5 | C0010606 | |
| Disease | risk-taking behaviour | TET2 ERCC4 MAP2 TULP4 SLC24A2 LRFN5 PCDH15 BANK1 PARD3B EBF1 SHTN1 MSRA BARHL2 RBFOX1 | 5.11e-04 | 764 | 192 | 14 | EFO_0008579 |
| Disease | cortical surface area measurement | TET2 MAP2 COPS7A ZNF469 COCH BANK1 TICRR NYAP2 DOCK9 PARD3B EBF1 MED13L SHTN1 MSRA SCUBE1 KANSL1 MACF1 ERC2 RASL11B PDZD2 | 5.16e-04 | 1345 | 192 | 20 | EFO_0010736 |
| Disease | cup-to-disc ratio measurement | SALL1 TCF7 SASH1 ABI3BP TTC28 EML4 PPM1A RASL11B MARK2 PDZD2 | 5.48e-04 | 430 | 192 | 10 | EFO_0006939 |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 5.61e-04 | 25 | 192 | 3 | DOID:0050589 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 5.69e-04 | 156 | 192 | 6 | DOID:10283 (is_marker_for) | |
| Disease | unipolar depression, bipolar disorder | 5.69e-04 | 156 | 192 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 5.79e-04 | 103 | 192 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | extraversion | 6.21e-04 | 6 | 192 | 2 | EFO_0004317 | |
| Disease | Abnormality of vision | 6.21e-04 | 6 | 192 | 2 | C4025846 | |
| Disease | Pituitary Gland Adenoma | 6.21e-04 | 6 | 192 | 2 | EFO_1000478 | |
| Disease | childhood absence epilepsy (biomarker_via_orthology) | 6.21e-04 | 6 | 192 | 2 | DOID:1825 (biomarker_via_orthology) | |
| Disease | Tumor of Rete Testis | 6.21e-04 | 6 | 192 | 2 | C1720811 | |
| Disease | xeroderma pigmentosum (implicated_via_orthology) | 6.21e-04 | 6 | 192 | 2 | DOID:0050427 (implicated_via_orthology) | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 6.32e-04 | 26 | 192 | 3 | OBA_2045194 | |
| Disease | cholesterol to total lipids in IDL percentage | 6.37e-04 | 60 | 192 | 4 | EFO_0022233 | |
| Disease | sleep duration | 6.46e-04 | 362 | 192 | 9 | EFO_0005271 | |
| Disease | QRS-T angle | 6.59e-04 | 106 | 192 | 5 | EFO_0020097 | |
| Disease | coronary artery disease | CDK8 TET2 NCOA6 PREX1 NYAP2 DOCK9 PPP1R9A ARFGEF2 RNF213 MAGI3 PDLIM5 PPM1A SCUBE1 CSNK1G2 MARK4 RBFOX1 SMARCA4 ELL | 8.45e-04 | 1194 | 192 | 18 | EFO_0001645 |
| Disease | Malignant neoplasm of testis | 8.66e-04 | 7 | 192 | 2 | C0153594 | |
| Disease | progressive familial intrahepatic cholestasis (is_implicated_in) | 8.66e-04 | 7 | 192 | 2 | DOID:0070221 (is_implicated_in) | |
| Disease | hypertension | 9.51e-04 | 307 | 192 | 8 | EFO_0000537 | |
| Disease | monocyte count | TET2 INO80C LRRIQ4 LYST TBC1D14 SEMA4A PREX1 AP3D1 MAP3K19 NYAP2 SH2D3C SAE1 DIDO1 EBF1 IQCN MED13L TLN1 MARK4 ELL | 1.05e-03 | 1320 | 192 | 19 | EFO_0005091 |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.07e-03 | 31 | 192 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | white matter microstructure measurement | 1.09e-03 | 390 | 192 | 9 | EFO_0005674 | |
| Disease | Testicular Neoplasms | 1.15e-03 | 8 | 192 | 2 | C0039590 | |
| Disease | microcephaly (is_implicated_in) | 1.15e-03 | 8 | 192 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | colorectal cancer (is_implicated_in) | 1.20e-03 | 121 | 192 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Alzheimer disease, educational attainment | 1.22e-03 | 247 | 192 | 7 | EFO_0011015, MONDO_0004975 | |
| Disease | vital capacity | TET2 NCOA6 MAP2 ZZEF1 TULP4 NYAP2 INTS12 CAMK2G WWP2 ARFGEF2 C16orf96 EBF1 SHTN1 KANSL1 ERC2 PATJ GAB1 PDZD2 | 1.25e-03 | 1236 | 192 | 18 | EFO_0004312 |
| Disease | reaction time measurement | TET2 BANK1 TTC28 EML4 PPP1R9A DGKZ PARD3B TACC2 MED13L ARSB KANSL1 RBFOX1 | 1.33e-03 | 658 | 192 | 12 | EFO_0008393 |
| Disease | aortic measurement | 1.34e-03 | 251 | 192 | 7 | EFO_0020865 | |
| Disease | age-related hearing impairment | 1.34e-03 | 324 | 192 | 8 | EFO_0005782 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.40e-03 | 74 | 192 | 4 | EFO_0022280 | |
| Disease | autoimmune thyroid disease | 1.43e-03 | 126 | 192 | 5 | EFO_0006812 | |
| Disease | Xeroderma pigmentosum | 1.47e-03 | 9 | 192 | 2 | cv:C0043346 | |
| Disease | urticaria, response to non-steroidal anti-inflammatory, angioedema | 1.47e-03 | 9 | 192 | 2 | EFO_0005531, EFO_0005532, EFO_0005533 | |
| Disease | reticulocyte measurement | CRISP2 ZNF469 USP42 NFIL3 PREX1 SMIM24 LETM2 NYAP2 ARFGEF2 LARP1 EBF1 SPECC1 KANSL1 MARK4 ELL PDZD2 | 1.51e-03 | 1053 | 192 | 16 | EFO_0010700 |
| Disease | posterior thigh muscle fat infiltration measurement | 1.52e-03 | 35 | 192 | 3 | EFO_0020934 | |
| Disease | smoking status measurement | ERCC4 ANKUB1 SALL1 TULP4 PCDH15 NYAP2 WWP2 DGKZ SHTN1 MSRA ACTR1B KANSL1 BARHL2 RBFOX1 ERC2 KDM4A ELL | 1.59e-03 | 1160 | 192 | 17 | EFO_0006527 |
| Disease | birth weight, parental genotype effect measurement | 1.66e-03 | 192 | 192 | 6 | EFO_0004344, EFO_0005939 | |
| Disease | unipolar depression, alcohol dependence | 1.70e-03 | 78 | 192 | 4 | EFO_0003761, MONDO_0007079 | |
| Disease | comparative body size at age 10, self-reported | 1.81e-03 | 420 | 192 | 9 | EFO_0009819 | |
| Disease | hip bone mineral density, age at menarche | 1.83e-03 | 10 | 192 | 2 | EFO_0004703, EFO_0007702 | |
| Disease | alopecia areata (is_marker_for) | 1.83e-03 | 10 | 192 | 2 | DOID:986 (is_marker_for) | |
| Disease | sleep time | 1.83e-03 | 10 | 192 | 2 | EFO_0005274 | |
| Disease | alpha wave measurement, electroencephalogram measurement | 1.83e-03 | 10 | 192 | 2 | EFO_0004357, EFO_0006870 | |
| Disease | insulin measurement | 1.90e-03 | 267 | 192 | 7 | EFO_0004467 | |
| Disease | pulse pressure measurement | TET2 ANKUB1 CYTH1 CDK14 AP3D1 LETM2 NYAP2 TTC28 WWP2 RNF213 ABCC9 EBF1 MED13L PDLIM5 MSRA KANSL1 FAM171A2 UBR3 ELL | 1.92e-03 | 1392 | 192 | 19 | EFO_0005763 |
| Disease | wellbeing measurement | ERCC4 RTKN2 LRFN5 PREX1 SLC27A2 NYAP2 ARFGEF2 PELI1 SIK3 MSRA ASXL3 RBFOX1 | 2.02e-03 | 692 | 192 | 12 | EFO_0007869 |
| Disease | irritability measurement | 2.05e-03 | 82 | 192 | 4 | EFO_0009594 | |
| Disease | Hodgkins lymphoma | 2.05e-03 | 82 | 192 | 4 | EFO_0000183 | |
| Disease | invasive ductal carcinoma (is_marker_for) | 2.24e-03 | 40 | 192 | 3 | DOID:3008 (is_marker_for) | |
| Disease | neutrophil percentage of leukocytes | TET2 CA14 TBC1D14 PREX1 NYAP2 SH2D3C SAE1 EBF1 HDAC7 KANSL1 MARK4 | 2.29e-03 | 610 | 192 | 11 | EFO_0007990 |
| Disease | Congenital small ears | 2.41e-03 | 41 | 192 | 3 | C0152423 | |
| Disease | mean corpuscular hemoglobin concentration | CRISP2 AURKA PREX1 TICRR NYAP2 TTC28 ARFGEF2 LARP1 C16orf96 EBF1 NCOA4 SPECC1 HDAC7 RBFOX1 MACF1 ELL | 2.45e-03 | 1105 | 192 | 16 | EFO_0004528 |
| Disease | insomnia measurement | 2.59e-03 | 443 | 192 | 9 | EFO_0007876 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.65e-03 | 145 | 192 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | descending aortic diameter | 2.65e-03 | 88 | 192 | 4 | EFO_0021788 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.75e-03 | 447 | 192 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 2.76e-03 | 43 | 192 | 3 | EFO_0022290 | |
| Disease | Coffin-Siris syndrome | 3.13e-03 | 13 | 192 | 2 | C0265338 | |
| Disease | ovary epithelial cancer (is_marker_for) | 3.13e-03 | 13 | 192 | 2 | DOID:2152 (is_marker_for) | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 3.13e-03 | 13 | 192 | 2 | OBA_2045174 | |
| Disease | brain measurement, neuroimaging measurement | MAP2 FAM107B KTN1 SHTN1 MSRA ACTR1B KANSL1 MACF1 ERC2 RASL11B | 3.38e-03 | 550 | 192 | 10 | EFO_0004346, EFO_0004464 |
| Disease | body surface area | CYTH1 SPATA31C1 NFIL3 TICRR NSD1 DIDO1 MED13L SHTN1 DICER1 MACF1 PATJ | 3.41e-03 | 643 | 192 | 11 | EFO_0022196 |
| Disease | lean body mass | 3.52e-03 | 379 | 192 | 8 | EFO_0004995 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 3.64e-03 | 14 | 192 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | colorectal cancer (is_marker_for) | 3.72e-03 | 157 | 192 | 5 | DOID:9256 (is_marker_for) | |
| Disease | osteoarthritis, knee | 3.82e-03 | 158 | 192 | 5 | EFO_0004616 | |
| Disease | hearing impairment | 3.90e-03 | 98 | 192 | 4 | C1384666 | |
| Disease | platelet component distribution width | ZZEF1 FAM107B TBC1D14 PREX1 NYAP2 DOCK9 HDAC7 METTL24 TLN1 MARK4 MACF1 FYB1 | 4.08e-03 | 755 | 192 | 12 | EFO_0007984 |
| Disease | Germ Cell Cancer | 4.18e-03 | 15 | 192 | 2 | C0740345 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 4.18e-03 | 15 | 192 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | Embryonal Neoplasm | 4.18e-03 | 15 | 192 | 2 | C0027654 | |
| Disease | Neoplasms, Germ Cell and Embryonal | 4.18e-03 | 15 | 192 | 2 | C0027658 | |
| Disease | infant head circumference | 4.18e-03 | 15 | 192 | 2 | EFO_0004577 | |
| Disease | Germ cell tumor | 4.18e-03 | 15 | 192 | 2 | C0205851 | |
| Disease | Neoplasms, Embryonal and Mixed | 4.18e-03 | 15 | 192 | 2 | C0205852 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 4.18e-03 | 15 | 192 | 2 | DOID:13413 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VHFSNKLPARPQVEK | 761 | Q8NDB2 | |
| VEPAKHRVSFQPKLS | 191 | Q9HCE6 | |
| KNKTRNESPPVSALV | 161 | Q5T6M2 | |
| NKKPRISHFTQRAQP | 336 | P55199 | |
| RIPLQAQKLVSSHKP | 56 | O14965 | |
| PPLTEAQKNKLRHLS | 86 | Q9UBW8 | |
| TRLRHPVSTKANKVP | 386 | P51813 | |
| NDVAKQRAAPKVSPH | 116 | O14862 | |
| ISHRGPQADPKSRQK | 81 | A6NHR8 | |
| DSLVKAPQVAKTRNP | 511 | Q9H201 | |
| TEAPLNPSKNREKAA | 111 | P42025 | |
| VRLKHSQAQSKPTTP | 231 | Q9Y6D5 | |
| KLQALAEEPSQPHTR | 176 | Q5VV41 | |
| TPRAQKAIVNHPSAA | 1726 | Q68CP9 | |
| HKNPALKAQSGPVRS | 281 | Q01518 | |
| HLRTPSTKPKQENEG | 146 | Q5M775 | |
| RKANPQDKVHPIKSE | 91 | Q9Y2X7 | |
| RKANPQDKVHPNKAE | 91 | Q14161 | |
| QKKKVADHPNRTPSI | 271 | O60706 | |
| QPTPSLVVDHERLKN | 1321 | Q6PL18 | |
| DPFEKPANQVKRVHS | 81 | O94921 | |
| STHKTIKNPVNNVRP | 1861 | O75179 | |
| TPRHLNQKGKALPLS | 1001 | Q9UPY3 | |
| AQSKKPVSRPATAAA | 36 | Q7Z478 | |
| HQQNERKKPPVATEG | 321 | Q7Z478 | |
| RKNITHTPSTKAAVP | 356 | Q8N3C7 | |
| HIQNSKQPRVPSAKA | 306 | Q6W2J9 | |
| RQKREQSPSQHGKDP | 856 | Q5T5Y3 | |
| VNKHNELRKAVSPPA | 41 | P16562 | |
| NQHKISVPRAPTKEE | 736 | Q8IZT6 | |
| HPRNLVTNVALPVKS | 1656 | Q9C0F0 | |
| LPIQKHRNTETSKSP | 816 | O14617 | |
| NPPINTKSQAVKDRA | 61 | O15511 | |
| KDSAKSVPRQPGSHQ | 171 | Q7Z4M0 | |
| KERAASPHQVTPQAD | 2466 | Q96L73 | |
| DPTEKQQPKRLHVSN | 91 | A6NFN3 | |
| SIHENPPKAKATVNV | 546 | Q9H0B3 | |
| SPRQPHRQDKAATAI | 1106 | Q9H0B3 | |
| HKPQVTDKEANDPRL | 191 | Q96CB8 | |
| ALPGRKEQTPVAAKH | 36 | Q9UJ68 | |
| VTEGPTSKRAHIKPN | 686 | Q96NI6 | |
| TVQPIRPKSHSKAEA | 501 | P23352 | |
| PARQPESINLKASKS | 696 | Q8TEW8 | |
| QSPAIKKQLDRHLPS | 986 | Q9Y4B6 | |
| SVQPQSHKPQPTRKL | 186 | Q6PKG0 | |
| ERLKPTNPAAQKALT | 531 | P52948 | |
| PKSRHPEEQQKVLSL | 261 | Q96R47 | |
| AHQPNTLTLDRPSKK | 381 | Q6ZWB6 | |
| ATKHPQVTSPQATKE | 96 | Q2VYF4 | |
| PPASSKHKTAERQEK | 461 | Q71F56 | |
| LLQKNVSKRDPPSSH | 1186 | Q5TCQ9 | |
| PQTPLHTARVLQEDK | 311 | Q16644 | |
| NSEDPRKAHPVTNAI | 106 | Q16787 | |
| KSVEHSPKIHQRNDP | 6 | A6NIV6 | |
| SQKPLPKDKETNRNH | 931 | Q5T848 | |
| RSQASPPKQAKTVLA | 101 | Q5VTL7 | |
| LINCQSKKPEPTRTH | 186 | Q13480 | |
| PSQPQLRDKTQPHSK | 346 | P78368 | |
| KNHPAQARSLVEAPV | 971 | Q5VYM1 | |
| PVKRNKSSVRHTQPS | 2461 | O15018 | |
| PEVNSSALPHKLRIK | 316 | Q16649 | |
| NRPPNVDLTKFHKTS | 361 | O15117 | |
| HNPNVKDKPTVERFI | 201 | Q15438 | |
| RPNSIVPLSKKVHRN | 606 | Q7Z3B3 | |
| NASDLAPQKQRTKPL | 691 | O75164 | |
| AKNDPIELPTSRSKN | 91 | Q8NEV8 | |
| VPSKRQEALPLHQET | 186 | Q86UP2 | |
| ALEKTRAPHPDQVQT | 466 | Q96QE4 | |
| PPKRSSHSQEKLLQN | 101 | Q8IXW0 | |
| HRRSQLQPEPAKTKA | 361 | O15083 | |
| DSKQQNGPPRKHIVE | 231 | Q96HC4 | |
| KVRSHSTEPLPKLDN | 546 | Q9P242 | |
| LSRAQPVQSKPQKAS | 81 | Q9NR12 | |
| HLKKSSQVPRTEAPA | 186 | Q9NR12 | |
| KRSHSVPAPSIRKQI | 351 | Q6ZV29 | |
| VQLKPRSPDHVLKNT | 856 | Q9UPN3 | |
| SPPKVVEIGHQRQKT | 2006 | Q9UPN3 | |
| FSVETPKKEHQPLRN | 2156 | Q9UPN3 | |
| APKSRHPEEQQKVLS | 261 | Q96R48 | |
| KPRQQHRKLQLSGPS | 346 | A8MVW0 | |
| AHQQKFRLPASAEPK | 71 | Q8IZS5 | |
| VKAPHQVPVQSEKSR | 266 | O94913 | |
| QDPKSVRLPVSQNVH | 1041 | Q14686 | |
| VTPQESHKLRKPENG | 306 | Q13772 | |
| IVRNSKKRPASPSHN | 16 | Q6PI98 | |
| KTARIQAALPAAKPA | 1411 | Q96QU1 | |
| PKINHTFRPQVEKAV | 141 | Q8NFC6 | |
| SQTKDPTAVQPHLRK | 1341 | Q9P2D7 | |
| KAFKHPSIRNPVSLV | 251 | O75173 | |
| KAKAAARQPAPAIHS | 2046 | Q9P2D3 | |
| PHITQKFRDNPEASK | 1006 | Q9BZ29 | |
| EAQPKAPQSALHRLK | 551 | A6NNT2 | |
| VQKAPRLIPHAKTFS | 2206 | Q9H799 | |
| ARAHFEKQPPSNLRK | 51 | Q9BQW3 | |
| APQRTQQKDGKHPVL | 191 | Q96ST8 | |
| PAASEKQLTKSNAPR | 381 | P00367 | |
| IEKASVNRKPQLPQH | 261 | Q6VVX0 | |
| RPQKLINPVKTSRNH | 16 | Q9H098 | |
| QLHGPPRVKAVKSSE | 216 | P35613 | |
| HNESKKTAPRQEAIP | 786 | Q9BTC0 | |
| QSHVVPPLLRKTDQD | 56 | A8MV24 | |
| RAHFEKQPPSNLRKS | 51 | Q9UH73 | |
| PKQESNAVHESFRPK | 171 | Q9NY43 | |
| PDVTNIVQEKKHTPR | 426 | Q86X45 | |
| ASTSLPQKPHLKLAR | 1156 | Q6VMQ6 | |
| QSPSAPHHAVVQKRK | 2576 | Q99698 | |
| HPLPKRQALEKSNGT | 276 | Q5VZF2 | |
| PSHKVQRSVSANPKQ | 391 | Q7KZI7 | |
| VSSAHNPNKAEIPER | 476 | Q96L34 | |
| TKRAIALITNHPPEK | 216 | P15848 | |
| IHRQTPESKNATPTK | 156 | Q9HC35 | |
| KRRSAAPLHSDQQPV | 626 | Q13574 | |
| VKSSNKNPSRAEPLV | 556 | Q49AJ0 | |
| KQQAALERTVHPNSP | 96 | Q8WUI4 | |
| RAHFEKQPPSNLRKS | 51 | Q9H4W6 | |
| HKDQKTSVPPFNLRE | 186 | Q9ULX7 | |
| HRASKANKKPVQLPR | 111 | P49336 | |
| QDSSHTQGPPLKKVR | 391 | P49336 | |
| QAVSTAHPPTGKRLK | 136 | O43405 | |
| PHSQARAKETARQPL | 501 | Q8IWY4 | |
| ALAQQRKSKPPNVTA | 421 | Q9NSC2 | |
| PAATEKQLTKSNAPR | 381 | P49448 | |
| PEQLHTAKSATLPRK | 551 | Q6P995 | |
| NPAKRITADQALKHP | 256 | Q13555 | |
| QNHKFPKEKERNIPS | 226 | Q56UN5 | |
| VNKVKNKNRPEPHSD | 136 | Q03701 | |
| PHSESKDTSPKQRIQ | 181 | Q13474 | |
| HRKNFLLPQKSLSPQ | 56 | Q86WN2 | |
| NPAKRITASEALKHP | 256 | Q13557 | |
| RPKANGVKPSTVHIA | 46 | Q96FA3 | |
| VNTTPDKPKTASEHR | 21 | Q14469 | |
| HPAVAAQKPHSNTRK | 236 | Q5JXM2 | |
| QAQKEENPKKHRSHP | 76 | P0DPB5 | |
| AKKRIHNFSVINPVP | 351 | Q8IZC4 | |
| VSHKQQPSSTPEKRR | 201 | Q9BPW5 | |
| PSENTENKSQPKRLH | 106 | Q9NWB1 | |
| ENKSQPKRLHVSNIP | 111 | Q9NWB1 | |
| QPKVKAIISPRQRSH | 916 | Q9UQ35 | |
| RKPQDKKRQASPHLQ | 321 | Q8N205 | |
| KVTAPEAQAKPSAAR | 301 | Q9UI40 | |
| NSPQKPNDRDHKVRL | 321 | O14975 | |
| AHEKRPPILTSSKQD | 6 | Q9H1U9 | |
| KHQTNPRSRPRSKQE | 261 | Q96D09 | |
| EKAPLSREQHLQSPK | 726 | Q9H3S1 | |
| AAQLKSRVSPPFKQA | 941 | Q8TCU6 | |
| HQKQSRITPIQKPRG | 346 | P51532 | |
| SPVEAQQATEHRLKP | 16 | O75264 | |
| KEPQTKPSRHQRTEN | 36 | Q9NSC7 | |
| LQSLAKPKSQAPTRA | 56 | Q9NSC7 | |
| HQPTAAFSKNKVPSR | 1156 | Q9Y2K2 | |
| VHLRPVNQTARPKTK | 421 | A0MZ66 | |
| AQEIVKALSQRDPPH | 311 | Q9UBE0 | |
| SARPHAIVANKIDLP | 336 | Q9H4K7 | |
| SQPVNPKHSRRSEKK | 776 | Q75T13 | |
| AVSHQGKRNPKSPLA | 676 | Q9Y253 | |
| SPDANVKAAPQSRKA | 86 | Q8NHX4 | |
| AHEKRPPILTSSKQD | 6 | Q3SY17 | |
| PDTRPLHLAKKQETA | 1541 | Q9ULL5 | |
| KVQALSLPETQHPER | 391 | P0DKV0 | |
| VTQQPTKSPGKERHL | 1136 | O60287 | |
| LHAEAQSKIRQSPSP | 61 | Q96JY6 | |
| SQPDTRKQALKFHPL | 396 | A6NFN9 | |
| EKRQHSPRHKPNISN | 601 | Q70EK8 | |
| ANLPAKPAEEAQKHR | 321 | Q9P2M4 | |
| SHPNRKVPAKEEANA | 6 | Q96A04 | |
| AAKASNRKPSPQDIA | 2966 | Q63HN8 | |
| EHLQKSAKALRPTPQ | 796 | Q9NRJ4 | |
| PSFALHQKISRQKPR | 106 | P17039 | |
| VRIPNADPSTKKANS | 101 | P52740 | |
| INAAASQPPKKVSRV | 556 | Q9HCE3 | |
| SVNRSSVIPEHPKKQ | 506 | Q9H9J4 | |
| SAKPKVHNRQPRINS | 26 | O00308 | |
| RLNVKAQKLHPDGSP | 586 | Q7Z2Z1 | |
| VSKRATKKENSHPAP | 881 | Q7Z2Z1 | |
| DSPLDSKITPQKRHT | 1166 | Q7Z2Z1 | |
| KPRKNVSAAIPSSIH | 171 | Q8TAG5 | |
| QTHSKARNSPKLFPV | 81 | Q8N8B7 | |
| TQDHKPSNPLEKERI | 161 | P35813 | |
| TPAAPTARKQLDKEQ | 21 | O76021 | |
| STPRVIPNVHNKANK | 1161 | Q8NI35 | |
| RQHISVLKENSLPKP | 71 | A7XYQ1 | |
| PGPSHRIKKTVQVEQ | 81 | Q16181 | |
| PSPELKQQLTGHSKR | 2261 | Q9Y490 | |
| PRHTPTKSNTIVNRK | 1186 | Q9BX26 | |
| VSTPEVERKNPLHKS | 121 | O94885 | |
| RSVLQSINPAEPHKE | 526 | O75326 | |
| PAGAQLRQHTPSLKK | 351 | Q9Y5W5 | |
| IKRKQQDTPGSPDHR | 31 | O95359 | |
| PAAEAHARLKTQLPQ | 121 | Q6ZMU5 | |
| KIFIHRPDISKVNPS | 3656 | Q86WI1 | |
| ADISQKQVHRPLQTP | 176 | P36402 | |
| VQAHSPSRKFILKPA | 1476 | P11137 | |
| PSEQRKAEPGHTQRK | 3846 | Q96JG9 | |
| LSVQSKSHLRKNPPT | 1461 | Q96AY4 | |
| SSHKRKLSEPPLQLQ | 246 | A8MUI8 | |
| RHQIKSSSNIPCVPK | 186 | Q6ZT12 | |
| PKPQLTEVRKHLTAA | 71 | Q86TV6 | |
| HPHRNSKEVKNIPDD | 1271 | O43149 | |
| RSLSSELKKPQAHLP | 1201 | Q9Y2L5 | |
| PRPSIKKAQNSQAAR | 81 | Q8N5H7 | |
| RNAVKANISVHPDKL | 266 | Q9Y5Q8 | |
| HKRPKDPQNKERAST | 466 | Q92889 | |
| DRNVSVDSTHPTKKP | 681 | Q7Z7G0 | |
| PTKETNNIPNHRVLI | 286 | Q9HAU0 | |
| LEAEPKSQRSAVQKP | 501 | Q9NUQ3 | |
| TKPLSNHEKVVRPAL | 561 | Q14679 | |
| AKLKPHSLEPRSQEQ | 436 | Q9C0B0 | |
| AKRELHATTPLKNPN | 1876 | Q6N021 | |
| KSAHQRKSLAPEPVQ | 266 | Q6BDS2 | |
| PHPNASAEKARNVLA | 176 | Q9UPU7 | |
| THSKASPRIQELANP | 411 | P0DJG4 | |
| RKGKRQHSSPQNPLL | 126 | Q9H0D2 | |
| TPSDIKKQNHVTPSR | 2416 | Q5THJ4 | |
| GKRLAHPVASAQKEP | 391 | A6NN73 | |
| VSHAFLPRVPKVQSN | 166 | A6NMK8 | |
| RSRNHKTAKLPAPSI | 221 | Q13094 | |
| AHKSNATPVPEVASK | 271 | Q9ULJ8 |